UpDoc — First FDA-Cleared Clinical AI Platform for Real-Time Care Delivery (Updated 2026)
ENTITYUpDoc has received FDA clearance for its clinical AI platform, becoming the first FDA-cleared system to provide patient-facing AI clinical decision support. The platform uses large language models to provide patients with personalized clinical information and guidance. UpDoc's FDA clearance represents a significant regulatory milestone: FDA has approved a large language model-based system for direct patient use in clinical settings. This suggests FDA is developing pathways for generative AI medical devices and is willing to authorize systems for patient-facing applications. The clearance may signal a shift in FDA's approach to AI device regulation, moving from traditional device frameworks toward frameworks designed specifically for adaptive, learning systems. Other vendors and healthcare organizations are watching UpDoc's real-world performance closely to understand whether FDA-cleared patient-facing AI will gain clinical adoption and what safety or liability issues emerge. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.